US 5,215,914 A · Adherent and invasive mycoplasma

Abstract

The present invention relates to a novel mycoplasma isolated from the urine of patients with AIDS. The mycoplasma has unique morphological and pathobiological properties. The invention also relates to the antigens and antibodies of the novel mycoplasma, and methods of detection utilizing these antigens and antibodies. Antigenically and genetically, the mycoplasma is distinct from all other known mycoplasmas. The invention further relates to the DNA sequence of the novel mycoplasma and vaccines against the mycoplasma infection.

Claims1

Dependent claims

A biologically pure mycoplasma isolated from patients with AIDS comprising the mycoplasma designated ATCC 55252.

Dependencies are inferred from the claim text.

Facts

Application

07/800,370Filed 2 Dec 1991 · continuation in part

Priority

18 Jun 1986

Granted

1 Jun 1993

Term ends

Not estimatedThe source records don’t support an estimate.

Classification18 codes

C12N 7/00
Viruses
A61K 39/0241
Bacterial antigens: mollicutes, e.g. Mycoplasma, Erysipelothrix
C07K 14/30
From bacteria: from Mycoplasmatales, e.g. Pleuropneumonia-like organisms [PPLO]
C12N 1/205
Bacteria; Culture media therefor: bacterial isolates

Abstract

Claims1

Dependent claims

A biologically pure mycoplasma isolated from patients with AIDS comprising the mycoplasma designated ATCC 55252.

Dependencies are inferred from the claim text.

Adherent and invasive mycoplasma

Life of this patent

Abstract

Claims1

Adherent and invasive mycoplasma

Life of this patent

Abstract

Claims1